Lysogenic HSV virus.

BIOLOGICAL2 trials

Sponsors

West China Hospital

Conditions

HNSCCImmunotherapyLysogenic HSV VirusNeoadjuvant TherapyTargeted Therapy

Phase 1

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus

RecruitingNCT06741982

West China HospitalHNSCC, Immunotherapy, Lysogenic HSV Virus +2

Start: 2024-12-15End: 2026-12-15Target: 21Updated: 2024-12-19

A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

Active, not recruitingNCT07010120

West China HospitalHNSCC, Immunotherapy, Lysogenic HSV Virus +2

Start: 2025-06-10End: 2027-05-31Target: 29Updated: 2026-07-01